COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,244 Articles (22,733 medRxiv, 8,511 bioRxiv)

Most recent first Previous |  Page 1140: Articles 11391-11400  | Next

SARS-CoV-2 testing and COVID-19 related primary care use among people with citizenship, permanent residency, and temporary immigration status in British Columbia: Cross-sectional analysis of population-based administrative data
Wiedmeyer, M.-l., Goldenberg, S., Peterson, S., Wanigaratne, S., Machado, S., Tayyar, E., Braschel, M., Carrillo, R., Sierra-Heredia, C., Tuyisenge, G., Lavergne, M. R.
10.1101/2021.11.05.21265978 — Posted: 2021-11-09
Parents intention to vaccinate their 5-11 years old children with the COVID-19: vaccine rates, predictors and the role of incentives
Shmueli, L.
10.1101/2021.11.05.21265900 — Posted: 2021-11-09
Forecasting the COVID-19 Pandemic: Lessons learned and future directions
Sundar, S., Schwab, P., Tan, J. Z. H., Romero-Brufau, S., Celi, L. A., Wangmo, D., Della Penna, N.
10.1101/2021.11.06.21266007 — Posted: 2021-11-09
Internet-based health survey on loneliness and sleep-related problems among the working-age population in Japan during COVID-19
Tesen, H., Konno, Y., Tateishi, S., Hino, A., Tsuji, M., Ogami, A., Nagata, M., Muramatsu, K., Yoshimura, R., Fujino, Y.
10.1101/2021.11.07.21266001 — Posted: 2021-11-09
Refining reproduction number estimates to account for unobserved generations of infection in emerging epidemics
Brizzi, A., O'Driscoll, M., Dorigatti, I.
10.1101/2021.11.08.21266033 — Posted: 2021-11-09
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort.
Aldridge, R. W., Yavlinsky, A., Nguyen, V. G., Eyre, M. T., Shrotri, M., Navaratnam, A. M. D., Beale, S., Braithwaite, I., Byrne, T. E., Kovar, J., Fragaszy, E., Fong, E. W. L., Geismar, C. R., Patel, P., Rodger, A., Johnson, A. M., Hayward, A. C.
10.1101/2021.11.05.21265968 — Posted: 2021-11-09
Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control-the prospective COVAC-DM cohort study
Sourij, C., Tripolt, N. J., Aziz, F., Aberer, F., Forstner, P., Obermayer, A., Kojzar, H., Kleinhappl, B., Pferschy, P. N., Mader, J. K., Cvirn, G., Goswami, N., Wachsmuth, N., Eckstein, M. L., Mueller, A., Abbas, F., Lenz, J., Steinberger, M., Knoll, L., Krause, R., Stradner, M. H., Schlenke, P., Sareban, N., Prietl, B., Kaser, S., Moser, O., Steinmetz, I., Sourij, H.
10.1101/2021.11.05.21265849 — Posted: 2021-11-09
Delta subvariants of SARS-COV-2 in Israel, Qatar and Bahrain: Optimal vaccination as an effective strategy to block viral evolution and control the pandemic
Yang, X.-J.
10.1101/2021.11.01.21265445 — Posted: 2021-11-09
Favipiravir In Adults with Moderate to Severe COVID-19: A Phase 3 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.
Shenoy, S., Munjal, S., Al Youha, S., Alghounaim, M., Almazeedi, S., Alshamali, Y., Kaszynski, R. H., Al-Sabah, S. K., Kuwait Clinical Trial Group
10.1101/2021.11.08.21265884 — Posted: 2021-11-09
Third dose vaccine With BNT162b2 and its response on Long COVID after Breakthrough infections
hoque, a., Rahman, M., Imam, H., Nahar, N., Hasan Chowdhury, F. U.
10.1101/2021.11.08.21266037 — Posted: 2021-11-09 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).